Reimbursement

Update:

the reimbursement of Velcade® (bortezomib) should be requested through eHealth as of 1/5/2018. In addition, the Velcade list price 3,5 mg and 1 mg has been decreased.

For more information, please download the official communication.

Supporting materials

Risk minimisation plan (RMP)​

  • Updated Velcade RMA materials (RMA: risk minimisation activities) are now available. The RMP includes the necessary measures to guarantee safe and effective use of Velcade and includes following documents for health care professionals (HCP):​
    • Summary of Product Characteristics
    • Reconstitution, dosing and administration booklet
    • Reconstitution poster
    • Dosing slide rule
    • Inducation transplant regimen graphs